Brii Biosciences Limited (BRIBF)
OTCMKTS · Delayed Price · Currency is USD
0.1882
+0.0015 (0.80%)
At close: Jan 7, 2026
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of $132.91 million as of February 6, 2026. Its market cap has increased by 24.83% in one year.
Market Cap
132.91M
Enterprise Value
-164.26M
Revenue
4.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 2.09B to 132.91M, a decrease of -93.63%. That is a compound annual growth rate of -45.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 132.91M | 1.73% |
| Dec 31, 2025 | 130.64M | 41.60% |
| Dec 31, 2024 | 92.26M | -56.66% |
| Dec 29, 2023 | 212.88M | -69.02% |
| Dec 30, 2022 | 687.16M | -77.39% |
| Dec 31, 2021 | 3.04B | 45.61% |
| Jul 13, 2021 | 2.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 308.99M |
| Silence Therapeutics | 228.61M |
| Vaxart | 154.67M |
| HST Global | 139.70M |
| BioStem Technologies | 109.20M |
| Nuo Therapeutics | 78.70M |
| Arch Biopartners | 53.28M |
| VitaSpring Biomedical | 51.78M |